Mayne Pharma Group Ltd has released a press release.
2017 CEOs Speech
Filed with ASX ·
On 6ix: 6ix.com/news/2017-ceos-speech
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
In the deck
Story so far
Earlier from Mayne Pharma
- Mayne Pharma launches clozapine tablets in the US
- Mayne Pharma adds two products to its Australian portfolio
- FDA approval and first generic launch of Acticlate tablets
- Clarification statement
- Mayne Pharma acquires rights to generic Duragesic in the US
Later from Mayne Pharma
- 2018 Half Year Media Release
- 2018 Half Year Investor Presentation
- First generic launch of Ritalin LA 10mg capsules in the US
- Mayne Pharma launches doxycycline IR capsules in the US
- Mayne Pharmas generic NuvaRing accepted for filing by FDA
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma